10 Best Undervalued Stocks Smart Money Is Buying for October 2025

10 Best Undervalued Stocks Smart Money Is Buying for October 2025

Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io

Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.

Market Overview & Selection Criteria

The current market landscape is characterized by robust growth in technology, steady performance in healthcare, and renewed interest in consumer and industrial sectors. Our selection methodology emphasizes intrinsic value, quality ratings, and recent financial performance. Each stock is evaluated using ValueSense’s proprietary metrics, focusing on companies with strong fundamentals, attractive valuations, and sectoral diversification. This approach aims to highlight undervalued stocks with compelling growth or recovery potential, balancing risk and opportunity for a diversified portfolio.

Stock #1: Taiwan Semiconductor Manufacturing Company Limited (TSM)

MetricValue
Market Cap$1,554.9B
Quality Rating8.3
Intrinsic Value$398.9
1Y Return60.3%
RevenueNT$3,401.2B
Free Cash FlowNT$947.9B
Revenue Growth39.5%
FCF margin27.9%
Gross margin58.6%
ROIC34.6%
Total Debt to Equity0.0%

Investment Thesis

Taiwan Semiconductor Manufacturing Company (TSMC) stands as the world’s leading pure-play semiconductor foundry, powering global technology giants with its advanced chip manufacturing. With a market cap of $1,554.9B and a quality rating of 8.3, TSMC’s dominant position is reinforced by its impressive revenue growth of 39.5% and a 1-year return of 60.3%. The company’s intrinsic value $398.9 suggests further upside potential, supported by robust free cash flow NT$947.9B and a high ROIC of 34.6%.

TSMC’s financial strength is evident in its gross margin of 58.6% and a pristine total debt to equity of 0.0%, indicating a fortress balance sheet. The company’s ability to consistently deliver high margins and cash flow, even amid cyclical industry swings, underpins its long-term investment appeal.

Key Catalysts

  • Ongoing global demand for advanced chips in AI, automotive, and consumer electronics
  • Leadership in cutting-edge process technologies (3nm, 2nm)
  • Strategic partnerships with major technology firms
  • Expansion of manufacturing capacity to meet secular growth

Risk Factors

  • Geopolitical tensions in the Asia-Pacific region
  • Cyclical downturns in semiconductor demand
  • High capital expenditure requirements for technology leadership

Stock #2: SAP SE (SAP)

MetricValue
Market Cap$314.8B
Quality Rating6.9
Intrinsic Value$309.2
1Y Return17.6%
Revenue€35.9B
Free Cash Flow€6,491.0M
Revenue Growth10.3%
FCF margin18.1%
Gross margin73.5%
ROIC15.1%
Total Debt to Equity21.2%

Investment Thesis

SAP SE is a global leader in enterprise software, enabling digital transformation for businesses worldwide. With a market cap of $314.8B and a quality rating of 6.9, SAP’s strong gross margin of 73.5% and free cash flow of €6,491.0M highlight its operational efficiency. The company’s intrinsic value $309.2 and 1-year return of 17.6% reflect steady performance and resilience in a competitive sector.

SAP’s revenue growth of 10.3% and ROIC of 15.1% demonstrate its ability to generate value from its core business. The company’s diversified product suite and recurring revenue streams from cloud services position it well for continued growth.

Key Catalysts

  • Accelerated adoption of cloud-based enterprise solutions
  • Expansion into AI-driven analytics and automation
  • Strong customer retention and upselling opportunities
  • Strategic acquisitions to broaden product offerings

Risk Factors

  • Intense competition from other enterprise software providers
  • Currency fluctuations impacting international revenue
  • Execution risks in large-scale digital transformation projects

Stock #3: Cisco Systems, Inc. (CSCO)

MetricValue
Market Cap$273.6B
Quality Rating6.9
Intrinsic Value$77.8
1Y Return23.4%
Revenue$56.7B
Free Cash Flow$13.3B
Revenue Growth5.3%
FCF margin23.5%
Gross margin65.1%
ROIC13.3%
Total Debt to Equity63.3%

Investment Thesis

Cisco Systems is a foundational player in global networking, cybersecurity, and cloud infrastructure. With a market cap of $273.6B and a quality rating of 6.9, Cisco’s revenue $56.7B and free cash flow $13.3B underscore its scale and financial flexibility. The company’s intrinsic value $77.8 and 1-year return of 23.4% signal continued relevance in a rapidly evolving tech landscape.

Cisco’s gross margin of 65.1% and FCF margin of 23.5% reflect strong profitability, while a ROIC of 13.3% indicates efficient capital allocation. The company’s focus on recurring software revenues and security solutions supports its transition to a more resilient business model.

Key Catalysts

  • Growth in cloud networking and cybersecurity demand
  • Expansion of subscription-based software offerings
  • Strategic acquisitions to enhance technology stack
  • Global infrastructure upgrades (5G, IoT)

Risk Factors

  • Competitive pressures from emerging networking firms
  • Technology shifts requiring ongoing innovation
  • Exposure to global supply chain disruptions

Stock #4: Novartis AG (NVS)

MetricValue
Market Cap$254.7B
Quality Rating7.3
Intrinsic Value$141.9
1Y Return12.2%
Revenue$54.6B
Free Cash Flow$16.8B
Revenue Growth13.3%
FCF margin30.8%
Gross margin56.0%
ROIC20.0%
Total Debt to Equity77.6%

Investment Thesis

Novartis AG is a leading global healthcare company with a focus on innovative pharmaceuticals. With a market cap of $254.7B and a quality rating of 7.3, Novartis combines steady revenue growth 13.3% with a robust free cash flow $16.8B. Its intrinsic value $141.9 and 1-year return of 12.2% highlight its defensive qualities and growth prospects.

The company’s gross margin of 56.0% and FCF margin of 30.8% reflect operational strength, while a ROIC of 20.0% demonstrates effective capital deployment. Novartis’s diversified pipeline and global reach support its long-term outlook.

Key Catalysts

  • Launch of new blockbuster drugs and therapies
  • Expansion in emerging healthcare markets
  • Ongoing R&D investment and innovation
  • Strategic divestitures to focus on core assets

Risk Factors

  • Regulatory and patent risks in pharmaceuticals
  • Pricing pressures in global healthcare markets
  • Pipeline execution and clinical trial outcomes

Stock #5: Micron Technology, Inc. (MU)

MetricValue
Market Cap$226.0B
Quality Rating8.4
Intrinsic Value$333.8
1Y Return85.6%
Revenue$37.4B
Free Cash Flow$8,929.0M
Revenue Growth48.9%
FCF margin23.9%
Gross margin39.8%
ROIC19.6%
Total Debt to Equity28.5%

Investment Thesis

Micron Technology is a key player in memory and storage solutions, benefiting from secular growth in data-centric applications. With a market cap of $226.0B and a quality rating of 8.4, Micron’s revenue growth of 48.9% and 1-year return of 85.6% underscore its momentum. The company’s intrinsic value $333.8 and free cash flow $8,929.0M highlight its strong financial position.

Micron’s gross margin of 39.8% and ROIC of 19.6% reflect solid profitability, while a total debt to equity of 28.5% indicates prudent leverage. The company’s exposure to AI, cloud, and automotive markets positions it for continued growth.

Key Catalysts

  • Rising demand for DRAM and NAND in AI and cloud computing
  • Expansion into automotive and industrial memory markets
  • Technology leadership in next-generation memory
  • Operational leverage from scale and efficiency

Risk Factors

  • Cyclical volatility in memory pricing
  • Capital intensity of semiconductor manufacturing
  • Competitive pressures from global memory suppliers

Stock #6: American Express Company (AXP)

MetricValue
Market Cap$225.5B
Quality Rating6.2
Intrinsic Value$363.5
1Y Return15.7%
Revenue$76.9B
Free Cash Flow$11.1B
Revenue Growth8.1%
FCF margin14.4%
Gross margin82.5%
ROIC(121.9%)
Total Debt to Equity184.8%

Investment Thesis

American Express is a premier global payments and financial services provider. With a market cap of $225.5B and a quality rating of 6.2, AXP’s gross margin of 82.5% and free cash flow $11.1B highlight its profitability. The company’s intrinsic value $363.5 and 1-year return of 15.7% reflect its resilience and brand strength.

AXP’s revenue growth of 8.1% and ROIC of 121.9% (noting negative ROIC due to accounting factors) are balanced by a high total debt to equity of 184.8%, typical for financial firms. Its focus on premium customers and digital innovation supports long-term growth.

Key Catalysts

  • Expansion of digital payments and fintech partnerships
  • Growth in premium cardholder base
  • Recovery in global travel and entertainment spending
  • Strategic investments in technology infrastructure

Risk Factors

  • Credit risk and economic sensitivity
  • Competition from fintech disruptors
  • Regulatory changes in financial services

Stock #7: Uber Technologies, Inc. (UBER)

MetricValue
Market Cap$193.5B
Quality Rating7.4
Intrinsic Value$204.8
1Y Return13.0%
Revenue$47.3B
Free Cash Flow$8,540.0M
Revenue Growth18.2%
FCF margin18.0%
Gross margin39.7%
ROIC66.4%
Total Debt to Equity52.2%

Investment Thesis

Uber Technologies is a global leader in mobility and delivery services, transforming urban transportation. With a market cap of $193.5B and a quality rating of 7.4, Uber’s revenue growth of 18.2% and free cash flow $8,540.0M highlight its improving financial profile. The company’s intrinsic value $204.8 and 1-year return of 13.0% reflect its transition to profitability.

Uber’s gross margin of 39.7% and ROIC of 66.4% (noting high returns from recent profitability) support its growth narrative. The company’s scale and network effects drive competitive advantages in both ride-hailing and delivery.

Key Catalysts

  • Expansion of mobility and delivery platforms
  • Growth in advertising and new business lines
  • International market penetration
  • Ongoing cost optimization and efficiency gains

Risk Factors

  • Regulatory and legal challenges in key markets
  • Competition from local and global mobility players
  • Sensitivity to fuel and labor costs

Stock #8: The Boeing Company (BA)

MetricValue
Market Cap$160.3B
Quality Rating5.8
Intrinsic Value$235.7
1Y Return36.8%
Revenue$75.3B
Free Cash Flow($8,117.0M)
Revenue Growth2.4%
FCF margin(10.8%)
Gross margin(0.3%)
ROIC(8.3%)
Total Debt to Equity(1,617.8%)

Investment Thesis

Boeing is a major aerospace and defense manufacturer, positioned for recovery as global air travel rebounds. With a market cap of $160.3B and a quality rating of 5.8, Boeing’s 1-year return of 36.8% signals investor optimism. However, negative free cash flow $8,117.0M and gross margin -0.3% reflect ongoing operational challenges.

Boeing’s revenue growth of 2.4% and ROIC of 8.3% indicate a turnaround phase, with high total debt to equity -1,617.8% highlighting leverage risks. The company’s recovery depends on successful execution of aircraft deliveries and cost controls.

Key Catalysts

  • Recovery in commercial aviation demand
  • Resolution of supply chain and production issues
  • Expansion in defense and space contracts
  • New aircraft programs and innovation

Risk Factors

  • Execution risks in aircraft production
  • Regulatory scrutiny and certification delays
  • High leverage and financial risk

Stock #9: Unilever PLC (UL)

MetricValue
Market Cap$153.4B
Quality Rating7.3
Intrinsic Value$97.8
1Y Return-0.2%
Revenue€120.1B
Free Cash Flow€14.5B
Revenue Growth2.5%
FCF margin12.1%
Gross margin71.3%
ROIC32.1%
Total Debt to Equity160.7%

Investment Thesis

Unilever is a global consumer goods powerhouse, offering stability and scale in essential products. With a market cap of $153.4B and a quality rating of 7.3, Unilever’s gross margin of 71.3% and free cash flow €14.5B support its defensive profile. The company’s intrinsic value $97.8 and 1-year return of -0.2% reflect recent market challenges but long-term resilience.

Unilever’s revenue growth of 2.5% and ROIC of 32.1% highlight efficient operations, while a total debt to equity of 160.7% is manageable for its sector. The company’s global brand portfolio and emerging market exposure underpin its steady outlook.

Key Catalysts

  • Expansion in emerging markets
  • Product innovation and premiumization
  • Sustainability initiatives and cost savings
  • Strategic acquisitions and divestitures

Risk Factors

  • Currency volatility and inflationary pressures
  • Shifting consumer preferences
  • Competitive pressures in key categories

Stock #10: Anheuser-Busch InBev SA/NV (BUD)

MetricValue
Market Cap$122.7B
Quality Rating7.1
Intrinsic Value$72.8
1Y Return-5.8%
Revenue$73.5B
Free Cash Flow$11.7B
Revenue Growth22.7%
FCF margin15.9%
Gross margin55.7%
ROIC17.3%
Total Debt to Equity82.7%

Investment Thesis

Anheuser-Busch InBev is a leading global brewer with a vast portfolio of iconic brands. With a market cap of $122.7B and a quality rating of 7.1, BUD’s revenue growth of 22.7% and free cash flow $11.7B highlight its scale and recovery potential. The company’s intrinsic value $72.8 and 1-year return of -5.8% reflect recent headwinds but underlying value.

BUD’s gross margin of 55.7% and ROIC of 17.3% support its profitability, while a total debt to equity of 82.7% is typical for the industry. The company’s global reach and brand strength provide a foundation for long-term growth.

Key Catalysts

  • Recovery in global beverage demand
  • Expansion in premium and non-alcoholic segments
  • Operational efficiencies and cost controls
  • Strategic brand marketing initiatives

Risk Factors

  • Currency and commodity price volatility
  • Regulatory and tax risks in key markets
  • Shifts in consumer preferences

Portfolio Diversification Insights

This watchlist spans technology (TSM, CSCO, MU, SAP, UBER), healthcare (NVS), financials (AXP), consumer staples (UL, BUD), and industrials (BA), providing sectoral balance and risk mitigation. High-growth tech names are offset by defensive consumer and healthcare stocks, while cyclical exposure is managed through diversified industry representation. This blend supports resilience across market cycles and offers multiple avenues for potential outperformance.

Market Timing & Entry Strategies

Given the diversity of this portfolio, staggered entry and dollar-cost averaging can help manage volatility and reduce timing risk. Investors may consider entering positions during sector pullbacks or after earnings releases to capitalize on price dislocations. Monitoring macroeconomic trends and company-specific catalysts is essential for optimizing entry points, especially in cyclical and high-growth sectors.


Explore More Investment Opportunities

For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:

📌 50 Undervalued Stocks (Best overall value plays for 2025)

📌 50 Undervalued Dividend Stocks (For income-focused investors)

📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)

🔍 Check out these stocks on the Value Sense platform for free!



FAQ Section

Q1: How were these stocks selected?
These stocks were chosen using ValueSense’s proprietary intrinsic value and quality rating models, focusing on companies with strong fundamentals, attractive valuations, and sector diversification based on the latest financial data and market trends.

Q2: What's the best stock from this list?
Each stock offers unique strengths; for high growth and quality, TSM and MU stand out, while NVS and UL provide defensive stability. The "best" depends on individual investment goals and risk tolerance.

Q3: Should I buy all these stocks or diversify?
Diversification is key to managing risk. This watchlist is designed to provide sectoral balance, allowing investors to tailor allocations based on their preferences and market outlook.

Q4: What are the biggest risks with these picks?
Risks include sector-specific volatility, geopolitical events (notably for TSM and BA), regulatory changes (NVS, UBER), and macroeconomic headwinds. Each stock’s section details its primary risk factors.

Q5: When is the best time to invest in these stocks?
Optimal timing varies by stock and sector. Consider entering positions during market corrections, after earnings reports, or when company-specific catalysts emerge. Dollar-cost averaging can help mitigate timing risk.